Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Total Non-Current Liabilities (2020 - 2021)

NeuroPace has reported Total Non-Current Liabilities over the past 2 years, most recently at $60.1 million for Q4 2021.

  • For Q4 2021, Total Non-Current Liabilities fell 3.26% year-over-year to $60.1 million; the TTM value through Dec 2021 reached $60.1 million, down 3.26%, while the annual FY2021 figure was $60.1 million, 3.26% down from the prior year.
  • Total Non-Current Liabilities for Q4 2021 was $60.1 million at NeuroPace, up from $59.3 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $65.1 million in Q1 2021 and troughed at $58.3 million in Q2 2021.